retatrutide dosing human trials Dosing: Administration Guide 2026 Retatrutide Dosage: What Clinical Trial

Different doses (5MG, 10MG, 15MG) are tested to evaluate how exposure levels influence pathway activity

10.1210/endo.138.10.5270 Endocrinology 39 LennoxR.FlattP

Common patch ingredients (berberine, green tea extract, cinnamon) have modest metabolic evidence when taken orally at high doses, but zero published pharmacokinetic data shows they absorb through the skin from an adhesive patch at therapeutic levels

23, Novo Nordisk released late-stage study results showing participants who took its next-generation obesity drug, CagriSema, didn't lose as much weight as those who took rival Eli Lilly's Zepbound

Larger Phase 3 studies are now underway to better define long-term efficacy and safety

The sample size for TRIUMPH4 is designed to provide at least 90% power to demonstrate the superiority of retatrutide 9 and 12 mg over placebo on each of the coprimary endpoints: percent change in body weight and percent change in WOMAC pain subscale score (with similar assumptions as above)